Marshall University

Marshall Digital Scholar
Biological Sciences Faculty Research

Biological Sciences

12-11-2019

Potential health risks linked to emerging contaminants in major
rivers and treated waters
James Kessler
Diane Dawley
Daniel Crow
Ramin Garmany
Philippe T. Georgel

Follow this and additional works at: https://mds.marshall.edu/bio_sciences_faculty
Part of the Endocrinology Commons

water
Review

Potential Health Risks Linked to Emerging
Contaminants in Major Rivers and Treated Waters
James Kessler 1 , Diane Dawley 2 , Daniel Crow 2 , Ramin Garmany 1 and Philippe T. Georgel 1,3, *
1
2
3

*

Department of Biological Sciences, Marshall University, Huntington, WV 25755, USA;
kessler42@live.marshall.edu (J.K.); garmany.ramin@mayo.edu (R.G.)
Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25755, USA;
dawleyd@live.marshall.edu (D.D.); dtcrow1@gmail.com (D.C.)
Department of Biological Sciences, College of Science, Cell Differentiation and Development Center,
Marshall University, Huntington, WV 25755, USA
Correspondence: georgel@marshall.edu; Tel.: +1-(304)-696-3965; Fax: +1-(304)-696-3766

Received: 30 October 2019; Accepted: 4 December 2019; Published: 11 December 2019




Abstract: The presence of endocrine-disrupting chemicals (EDCs) in our local waterways is becoming
an increasing threat to the surrounding population. These compounds and their degradation products
(found in pesticides, herbicides, and plastic waste) are known to interfere with a range of biological
functions from reproduction to differentiation. To better understand these effects, we used an in silico
ontological pathway analysis to identify the genes affected by the most commonly detected EDCs in
large river water supplies, which we grouped together based on four common functions: Organismal
injuries, cell death, cancer, and behavior. In addition to EDCs, we included the opioid buprenorphine
in our study, as this similar ecological threat has become increasingly detected in river water supplies.
Through the identification of the pleiotropic biological effects associated with both the acute and
chronic exposure to EDCs and opioids in local water supplies, our results highlight a serious health
threat worthy of additional investigations with a potential emphasis on the effects linked to increased
DNA damage.
Keywords: endocrine disrupting chemical; opioid; pathway analysis; ontology; metabolomics

1. Introduction
Outline: endocrine-disruption chemical (EDC) effects are not solely mediated by competing
for hormone receptors in cells, but may also be caused by an increase in reactive oxygen species,
leading to DNA damage. There is also a potential epigenetic effect linking to changes in levels of
DNA methylation
The quality of tap and drinking water is an important issue affecting most countries worldwide.
Contamination and its downstream effect on human health can vary widely between regions. In most
industrialized countries, a significant portion of the tap water used for daily consumption comes
from local waterways. Industrialization results in greater populations which necessitates larger water
sources, increasing the likelihood that various chemical contaminants will be present. Concerns about
water quality were initially triggered in the 1990s due to the presence of pharmaceuticals such as
antibiotics at detectable, biologically significant concentrations [1]. In addition, the requirement for
increased food production and the control of insect populations has led to the augmented use of
herbicides and pesticides. Simultaneously, urban development has coincided with an increased use of
detergents and plastic materials, leading to by-product dissipation in local water supplies. Of specific
concern among these emerging contaminants are endocrine disrupting chemicals (EDCs), compounds
which interfere with hormone metabolism in the body (National Institutes of Environmental Health
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Science: Endocrine disruptors fact sheet; for review, see [2] and opioids [3]). These polyphenolic
chemical structures found in waste, such as plastic containers, detergents, herbicides, and pesticides,
can mimic hormones and cause major disturbances (even at low concentrations) in cellular homeostasis,
functionality, and differentiation [4,5]. For example, links between EDCs and elevated cancer risks
have clearly been established [6]. In addition, exposure to EDCs has been demonstrated to negatively
impact the immune response [7], and compounding health factors, such as obesity, can exacerbate the
severity of this reaction [8]. Chronic exposure to EDCs in local waterways can also have environmental
consequences, including the feminization of several species of crustacea, fish, and other vertebrates [9].
Importantly, EDCs have been recognized to be capable of disrupting neuroendocrine processes,
modifying the patterns of expression and production in neurotransmitters, resulting in the alteration
of physiological and behavioral responses [10,11]. Another factor which may complicate the analysis
of the results of studies involving EDCs’ effects on organisms relates to the genetic variability in
individuals which, in turn, can lead to different biological responses to environmental exposures [12,13].
Although not yet fully understood, the molecular reactions to EDC exposure have recently been linked
with epigenetic changes, potentially affecting cells in a genome-wide manner [14].
To examine the potential biological effects of EDCs contaminating major waterways, we selected
commonly used polyphenolic hormone mimetics utilized as herbicides, insecticides, and detergent as
our representative examples (these products have been shown to be present in the Ohio River and
other major water sources, see Table 1 for detected concentrations and references). Data on EDC
concentrations in surface water, rivers, sediments, and tap water have been recorded for extended
periods of time. This data set is summarized in Table 1. Note that the range of concentrations
reported may be influenced by the location of collection of the samples. The proximity of chemical or
pharmaceutical plants, or even hospitals, may significantly affect the values reported (for example, see
the values reported for buprenorphine in Table 1). Also, note that the values reported do not reflect
toxicity, but simply the concentration of the various compounds investigated.
We selected atrazine as an herbicidal EDC example, as it is arguably the most commonly
used agricultural herbicide. It has been detected in tap water at levels above 3 ppb in 19 U.S.
states (https://www.ewg.org/tapwater). As for insecticides and pesticides, we decided to focus on
Chlorpyrifos (http://www.health.state.mn.us/divs/eh/risk/guidance/gw/chlorpyinfo.pdf. [15,16]) and
Endosulfan, two widely-used EDCs which have both been detected in major U.S. waterways [17,18]
and tap water (http://md.water.usgs.gov/nawqa; [18]).
Bisphenol A was chosen as a known organic wastewater EDC contaminant detected in various
large waterways world-wide, reaching median concentrations ranging from 0.016 to 0.5 µg/L in
reported European and U.S. studies [19]. It is also present at detectable levels in drinking water from
Asia, Europe and North America [20,21]. To complete our basic investigation, we included a very
common EDC detergent, known as Nonyl Phenol, commonly detected in water and accumulating in
sediments due to its poor solubility [22]. Despite standard tap water purification procedures, Nonyl
Phenol has been detected as a contaminant in tap water [23].
Recently, a significant increase in the use of opioids, as both a therapeutic agent and recreational
drug, has raised concerns that they will soon emerge as a major contaminant in local water treatment
facilities [24], Among addiction treatment options for opiate-abusing patients, buprenorphine has
become a popular alternative to methadone as a maintenance/weaning agent, particularly in the
Appalachian region [25]. As a result, renewed efforts to monitor local water treatment plants for
buprenorphine have been initiated. Highlighting a need for a more rigorous monitoring system,
a recent study in France has revealed the presence of hot spots in water treatment plants containing
buprenorphine levels capable of generating the biological responses known to affect brain function
and development [26,27].
In order to further understand the pleiotropic levels of disruption caused by EDC and
buprenorphine exposure, we undertook a bioinformatics in silico gene ontology investigation focused
on the various cellular functions and genetic pathways that are affected by these emerging contaminants
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detected in a variety of water sources worldwide [1]. Our goal for this analysis was to identify and
evaluate the potential biological effects and modes of action of each contaminant investigated. By
finding the common trends among these affected functions and pathways, we gained valuable insight
on the potential mechanisms of action of these emerging contaminants and outlined the alarming
possibility that additive and/or synergistic properties could enhance the deleterious effects resulting
from acute or long-term co-exposure from multiple sources.
2. Material and Methods
Ingenuity Pathway Analysis (IPA® , Ingenuity Pathway Analysis, Qiagen Corp, Germantown,
MD, USA): The identification of genes affected by the emerging contaminants was accomplished
using the Ingenuity Pathway Analysis software. Information related to each individual emerging
contaminant was entered into the software, resulting in a list of associated genes generated by the
Ingenuity Pathways Knowledge Base. The cellular network and localization of these genes were then
algorithmically elucidated using the IPA® mapping tools, allowing for the visualization of the various
interactive disease and functions nodes affected by each individual emerging contaminant. Matching
tables were compiled using the “BioProfiler” function of the IPA® mapping tool, and the display of our
analysis was focused on the gene’s symbols, synonyms(s), NCBI Entrez gene names, cellular location,
and nature/function (shown as “Family” in the tables). All of the compounds were analyzed for their
roles, links, and functions related to the following IPA® selection “Families”: Organismal injury, cell
death, organismal survival, cancer, and behavior (which were the top five functions outlined using
the default ontologic/metabolomic analytical “BioProfiler” as a basis for our specific analysis settings).
The tables and figures presented are based on our analysis and display all of the data generated by
the above-mentioned algorithm. The absence of data for any specific “Family” indicates a lack of
IPA-available information about the particular compound analyzed. All data were obtained without
statistical bias or any favorable weight assigned. For each “Family”, the tables were compiled to
present all the genes affected by a specific compound (see below for a more detailed algorithm and
Tables in Supplementary Data).
Enter name of Chemical investigated Select IPA Analysis Tool: Path Designer, Biomarker filters:
Path Explorer General Filter: Interactions Direct and Indirect; data Source: All; Species: All; All Tissues
and Cell Lines: All; Relation Types: All; Node Types: All; Diseases: All; Biofluids: All; Biomarkers: All;
Mutations: All. Select Option: Gens and Chemicals: Enter chemical name, run search. Select Analysis
Display in BioProfiler results. Select Display Option: Display by protein cellular location.
3. Results and Discussion
3.1. Atrazine: Standard Herbicide, Potential Carcinogen, and Environmental Immune Disruptor
Atrazine is an herbicide belonging to the triazine family (see Figure 1A for structure) that has
been widely used by agriculture workers in the USA for decades and has long been suspected to
have multiple deleterious effects on both invertebrates and vertebrates. Based on this suspicion,
it was banned in 2004 by the European Union, as the levels in ground water were exceeding the legal
limits considered safe for the environment (See European Commission Decision C (2004) 731 [28]).
Despite this fact, in 2003, the Environmental Protection Agency (EPA) estimated that “cumulative
exposures to these pesticides (atrazine and simazine) through food and drinking water are safe and
meet the rigorous human health standards set forth in the Food Quality Protection Act (FQPA).”
(http://www.epa.gov/pesticides/reregistration/atrazine/atrazine_update.htm#atrazine). This statement
was regarded as being highly controversial, as recent publications have indicated that chronic exposure
to the presence of atrazine and/or degradations products is likely to have serious negative effects on
human health [29]. To further investigate these potential effects of atrazine exposure, we performed
an in silico gene ontology analysis using the Ingenuity Pathway Analysis (IPA) software package,
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focusing on identifying how atrazine affects cellular functions, such as organismal injuries, cell death,
cancer and behavior.
(A) Organismal injury: As was expected, based on its chemical structure, atrazine has an effect
on the expression and cellular pathways of genes involved in hormonal responses. The testosterone,
estrone, estrogen, and estradiol pathways are all prime targets in atrazine-exposed cells (see Figure 1B
and Supplementary Materials Table S1). Increased levels of expression were noted for specific hormone
receptors, such as the androgen receptor (AR), glucocorticoid receptor (GR), growth hormone-releasing
hormone receptor (GHRHR), and the estrogen receptor (ER). The cytochrome p450 family genes
CYP11A1 and CYP19A1, known to be involved in drug metabolism and detoxification, were found to
be affected by atrazine exposure as well [30].
(B) Cell death: Many of the pathways and receptors associated with organismal injury are also
involved in atrazine-mediated cell death (Figure 1C and Supplementary Materials Table S2), in addition
to the growth factor CLEC11A, a member of the C-Type lectin superfamily-3 [31], and known to
be involved in apoptosis [32]. Based on our analysis, most of the genes that we identified to be
involved in the atrazine exposure response have been shown to be linked with triggering apoptosis
in fish [33], amphibians [34], and mice [35,36]. This effect can be mediated by changes in access to
membrane receptors, such as the glucocorticoid receptor (GR, [37,38]), a process which has been linked
with the gene NR3C1, coding for the glucocorticoid nuclear receptor variant 1 ([39], see Figure 1C).
The intra-cellular response involves detoxification through cytochrome p450 genes, such as CYP11A1
and CYP19A.1, Interestingly, these genes are also known as the key regulators in cytotoxicity and
apoptosis [30,40].
Table 1. Concentrations of emerging contaminants. Data were collected from various databases,
reports, and poster presentations. µg L−1 (microgram per liter), µg K−1 (microgram per kilogram)1.
ORSANCO, Ohio River, Evansville, IN (2016); 2. https://www.ewg.org/tapwater); 3. http://www.health.
state.mn.us/divs/eh/risk/guidance/gw/chlorpyinfo.pdf.
EDC

Concentration (ppb)

Atrazine (ppb1 )

0.19 to 1.88 (Ohio River)1

µg L−1

µg.K−1
(in Sediments)

Presence in
Tap/Drinking Water
Detected in 28 U.S. states2

0.016–0.5 [26–29]

Detected in Asia, Europe,
North America [26]

0–2.828 [30]

Detected in drinking
water3 [30]

Endosulfan

<1 (WHO), 0.020–0.11 [31]

Detected in drinking
water [31]

Nonyl Phenol

0.1–0.5 (Ohio Tributary) [32]
0000.1-0.0027 (Tap water,
Chongqing China [28])

Buprenorphine

0.042–0.195 (sewage water,
Paris) France [7]

Bis-Phenol A
Chlorpyrifos

0.24 (ground water, MN)3

75–340 (Ohio
Tributary) [32]

Detected in drinking
water [28,32]
Detected in waste water
[7,33,34]
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Figure 1. Atrazine. Panel A: Structure of atrazine and legend of symbols used for panels B to E
(as provided by Ingenuity Pathway Analysis (IPA) modeling “Bioprofiler” function). Panel B–E:
Cellular location and names of genes affected by atrazine exposure linked to, respectively, Panel B:
Cellular response to organismal injury, Panel C: Cell death, Panel D: Cancer. Panel E: Behavior. Note
that all symbols and genes names and functions are described in Supplementary Materials Tables S1–S4.
The data were generated using human and animal model data. They include information from in vivo
and in vitro experiments.

(C) Cancer: Again, the genes affected by atrazine exposure manifest their effects through responses
linked to hormone receptor pathways, involving various genes from the cytochrome p450 family
genes [30,41] (Figure 1D and Supplementary Materials Table S3). The dysregulation of the aromatase
CYP19, mediated by the steroidogenic factor 1 (SF-1), leads to increased risks of developing prostate
and breast cancers in human [42,43]. The general mechanism of action of atrazine is considered to
involve oxidative stress and the production of reactive oxygen species (ROS) and hydroxyl radicals,
processes which are known to contribute to increased DNA damage [41]. An increased DNA damage
response in human breast epithelial cells (MCF-10A) has recently been reported in response to atrazine
exposure-mediated DNA double-strand breaks [44]. The atrazine-mediated increase in the expression
of GATA4, a transcription factor involved in DNA damage response, confirms this connection [45].
GATA4 may also indirectly cause an increase in inflammation [46]. As an increasing amount of
evidence suggests a role for atrazine as an oncogenesis trigger in breast cancer, one may envision
that atrazine may soon be officially considered as a potential carcinogen, based on its xenoestrogen
properties as well as its ability to induce DNA double-strand breaks.
(D) Behavior: The effects attributed to an exposure to atrazine and behavior changes are
also mediated by hormone receptors and cytochrome p450 family genes [30,41] (Figure 1E and
Supplementary Materials Table S4). An exposure to low doses of atrazine has been shown to affect
the behaviors of young male mice [47,48]. The reproductive behaviors of male Drosophila have
also been shown to be affected by atrazine exposure [49]. Atrazine-mediated mis-regulation of
acetylcholinesterase was recently shown to affect defensive behavior in zebrafish [50].
As we investigated the effects of atrazine on various biological systems and functions, our results
indicate that this specific herbicide harbors a strong carcinogenic potential, as has been long
suspected [51]. As a hormone mimic, the main identified targets of atrazine are hormone receptors,
some of which (AR, GR, and ER) are strongly associated with breast [52,53] and/or prostate cancers [29].
These receptors are also involved in the processes of growth and development, therefore long-term
exposure should be considered potentially hazardous for developing aquatic and semi-aquatic animals
(amphibians, fish, etc.) [54], as well as mammals exposed to contaminated water [55,56]. In addition,
atrazine has also been recently associated with disruptions of immune evasion, a mechanism involved
in regulating tumor formation, progression, and evasion [57,58], and future studies are likely to
uncover additional effects mediated by atrazine exposure involving the immune response and their
connection with oncogenesis. Deficiencies in processes such as tumor evasion prevent one’s immune
system from recognizing and disposing of malignant tumors. Importantly, recent studies have also
linked exposure to atrazine with increased DNA damage in fish [59] and mammals [60], including
humans [44,61]. As previously mentioned, this aspect of atrazine toxicity is likely to be connected with
the increase in the formation of ROS caused by the reduced expression of cytochrome p450 family
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genes, hence leading to increased DNA damage. This effect on impeding DNA damage might give
a clue to the pluripotent effects of atrazine, as the increased presence of ROS will promote DNA single
and double-strand breaks, causing mutations and chromosomal instability.
3.2. Chlorpyrifos: Organophosphates and Their Neural and Hepatic Toxicities
The use of organophosphate insecticides is widespread in agriculture, despite being a frequent
source of poisoning around the world. In 2002, there were an estimated 3,000,000 cases of
organophosphate poisoning globally, which resulted in 300,000 deaths [62]. The United States
has had far fewer cases of lethal organophosphate poisoning reported compared to other developing
nations. This lower number might be partially due to better access to the main antidotes to chlorpyrifos
poisoning—atropine and pralidoxime. Nonetheless, organophosphates such as chlorpyrifos (for
structure, see Figure 2A) are still found in commercially available household insecticides, which
increases the average individual’s risk of exposure to these harmful compounds.
Although the modern use of organophosphates is generally limited to insecticides,
these compounds have also been used historically in chemical warfare due to their inherent lethality
in humans. While unfortunate, this has resulted in a wealth of anthropocentric research data not
available when compared to with many other insecticides. Examples of organophosphates include
physostigmine, which is naturally found in the Calabar bean and has been used for centuries in West
African witch trials [63], and sarin gas, first used during World War II and a known contributor to the
high rate of insecticide-mediated suicides in modern Asia [64]. On a molecular level, these deadly
chemicals exert their effects on the brain through the inhibition of the critical enzyme cholinesterase
(an enzyme involved in the degradation of the neurotransmitter acetylcholine).
Much of the early research on organophosphate toxicity failed to definitively link exposure to
any long-term effects in humans [65]. However, decades of investigation have followed and led to
a change of opinion, as several neuropsychiatric conditions have become strongly associated with
organophosphate exposure [66]. Broadly speaking, long-term toxicity results in similar symptoms to
those seen in acute exposure, and a single severe episode of acute poisoning may lead to chronic effects
long after functional cholinesterase levels are restored [67]. Adding to the current knowledge, our
study has linked organophosphate exposure to changes in gene expression involved in organismal
injury, cell death, cancer, and behavior (Figure 2B–E).
(A) Organismal injury: Chlorpyrifos exposure increases the expression of many genes
associated with stress (Figure 2B and Supplementary Materials Table S5). These include CRH
(corticotropin-releasing hormone), an important regulator in the hypothalamic–pituitary axis; GAL
(galanin), which may be neuroprotective; and ABCG2, a multi-drug resistance transporter gene.
The choline acetyltransferase-encoding gene ChAT was affected, which is not surprising considering
the direct mechanism of action of chlorpyrifos is through the inhibition of the cholinesterase enzyme.
Other gene targets of chlorpyrifos exposure include succinate dehydrogenase, one of the key enzymes
in the citric acid cycle and electron transport chain and Sod, a superoxide dismutase gene which is
important in apoptosis, and is linked with DNA damage.
(B) Cell death/survival: The cell death- and survival-associated genes targeted by chlorpyrifos
are similar to those involved in organismal injury (Figure 2C and Supplementary Materials Table S6).
Examples include Sod, ChAT, ABCG2, CRH, NPY, and GA. In addition, a heme-oxygenase encoding
gene known as HMOX1 is affected by chlorpyrifos exposure. Overall, the profile of cell death and
organismal injury targeted by chlorpyrifos activity demonstrates that the toxicity of this chemical
affects not only the existing cholinesterase enzyme, but also the genes which are key factors involved
in cell protection and metabolism.
(C) Cancer: Only three cancer-related genes were identified as being altered by chlorpyrifos
exposure, and all three were common to the other categories delineated in this paper: ChAT, GSR,
and HMOX 1 (see sections A, B, and D, Figure 2D and Supplementary Materials Table S7). GSR
encodes glutathione disulfide reductase, a highly conserved gene which is important for preventing
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oxidative stress in humans. This function is highly relevant in cancer, as the conversion of GSSG
(oxidated Glutathion) to GSH (Glutathion) promotes increased DNA synthesis, which aids the growth
and development of tumors [68].
(D) Behavior: The main behavior-related genes identified in this ontological study were ESR1, NR3C1,
and genes involved in the conversion of fatty acids or cholesterol to hormones. These include PTGS2,
CYP11A1, and CYP19A1, which encodes aromatase (Figure 2E and Supplementary Materials Table S8).
These findings suggest that chlorpyrifos exposure is closely associated with the production of sex steroids
and the resultant signaling pathways, via the estrogen receptor-encoding genes ESR1 and NR3C1.

Figure 2. Cont.
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Figure 2. Chlorpyrifos. Panel A: Structure of chlorpyrifos and legend of symbols used for panels B to
E (as provided by IPA modeling “Bioprofiler” function). Cellular location and names of genes affected
by chlorpyrifos exposure linked to, respectively, Panel B: Cellular response to organismal injury, Panel
C: Cell death/survival, Panel D: Cancer, Panel E: Behavior. Note that all symbols and genes names
and functions are described in Supplementary Materials Tables S5–S8. The data were generated using
human and animal model data. They include information from in vivo and in vitro experiments.

As was expected in the case for atrazine, based on its chemical structure, chlorpyrifos is a strong
disruptor of hormonal responses. However, its biological effects are more targeted towards the processes
involving cellular detoxification and glutathione (GSH) [68]. Although the majority of the data available
were generated using the planktonic crustacean Daphnia as a model system, several reports suggest
that its effects follow a similar mode of action in humans [69,70], also potentially mediated by GSH
availability. Recent studies of chlorpyrifos exposure also give indications that it may alter proper
brain function and development by impairing the cortical axon functions in rats [71], as well as proper
differentiation of neural stem cells into neuronal and glial cell phenotypes [72]. The links between
chlorpyrifos toxicity with cancer are less obvious than that observed with atrazine, as they are apparently
mediated by defective detoxification genes, such as GSR. This might be a secondary effect, possibly
related more to a potential red-ox imbalance (oxidative stress in general) than a direct carcinogenic
effect. As a potential link to this oxidative stress, DNA damage associated with chrlorpyrifos exposure
has been reported in various mammalian tissue, most notably in the brain [73].
3.3. Endosulfan: Pesticide
Endosulfan is an organochlorine cyclodiene pesticide (see Figure 3A for structure) considered to be
highly toxic because of its endocrine effects and high potential for bioaccumulation (EPA toxicity Class
I, for additional details see https://www.epa.gov/sites/production/files/2014-07/documents/chapter7_
revised_final_0714.pdf). Based on our analysis, all changes in organismal injuries, cell death, cancer
and behavior a similar sub-set of genes, which are generally associated with endosulfan’s ability
to be recognized as a hormone mimetic substance (Figure 3B and Supplementary Table S9). Most
reports on the toxicity of endosulfan are based on its biological effects on aquatic organisms [74].
In contrast, less information is available on its effects on humans, although initial reports, from as
early as 1982, described its potential bioaccumulation in humans as well as several other non-target
species (for more details, see [75]). Aquatic species appear to be more sensitive to the bioaccumulation
of endosulfan, therefore experiencing a higher toxicity [74–76]. According to studies performed on
various animal models and as seen with the previously-mentioned EDCs and based on its chemical
structure, endosulfan can predictably disrupt hormonal responses in both fish and mammals (including
humans) [77]. Our ontological study results identified a similar set of genes affected by endosulfan
exposure in all the investigated cellular-function scenarios. These deleterious effects can result in the
triggering of developmental issues in multiple cell types including, but not limited to, the reproductive
tracts [78]. Additionally, two important genes involved in cell proliferation, the estrogen receptor ESR1
and ESR2, are strongly affected by endosulfan exposure [11]. Another report associates endosulfan
toxicity with prolactin (PRL) expression [79], an effect which may also be mediated by changes in
expression of the nitric oxide synthase genes NOS1 and NOS2, altering the normal functions of the
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pituitary glands [80]. In addition, exposure to endosulfan has been linked to an increased incidence of
various types of cancers, with cell types involved in sexual development, primarily breast, as primary
targets [78–82]. Other tissues or cell types are also targeted, such as in colon cancer, in which jun/AP-1 is
the main pathway affected by endosulfan exposure known to date [83]. As a possible linkage to explain
its activity in cancer cells, endosulfan has been identified as an apoptotic agent [84]. The affected
cell types by this mode of action cover a wide spectrum, from human T-cells [84] and peripheral
mononuclear cells [85] to umbilical, embryonic, and placental cells [86].

Figure 3. Endosulfan. Panel A: Structure of endosulfan and legend of symbols used for panel B
(as provided by IPA modeling “Bioprofiler” function). Panel B: Cellular location and names of genes
affected by endosulfan exposure linked to cellular response to organismal injury, cell death, cancer,
and behavior. Note that all symbols and genes names and functions are described in Supplementary
Materials Table S9. The data were generated using human and animal model data. They include
information from in vivo and in vitro experiments.

As revealed in our chlorpyrifos analysis, the bulk of evidence for endosulfan toxicity uncovered
in our ontologic study was based on experiments performed using aquatic species. Nonetheless,
a small number of mammalian (mostly rat) studies on endosulfan exist providing valuable information
pertaining to human health. Exposure to endosulfan in young male rats interferes with normal
development of the mammary glands [87], an expected result for EDC toxicity. Recent work has
also linked endosulfan exposure to deficiencies in the brain and behavioral functions [88]. Aiming
to determine its general mechanism of action, additional studies have indicated that endosulfan
appears to be associated with an apparent increase in non-sequence-specific DNA damage (for review,
see Sebastian and Raghavan, 2017 [89]). This might explain how endosulfan can affect a large number
of genes involved in a variety of cellular functions instead of having more defined and specific genetic
targets. This potential mechanism of action involving genomic instability raises the possibility that
endosulfan displays carcinogenic properties.
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3.4. Nonyl Phenol and Nonyl Phenol Ethoxylates: Endocrine Disruptor
Nonyl phenol, or 4-nonyl phenol (NP), is a non-ionic surfactant (see Figure 4A for structure)
commonly derivatized to generate Nonyl phenol ethoxylates (NPE) which are used as emulsifiers,
detergents, and dispersing agents [90]. Since 2000, NP and NPE have been highly regulated in European
Union countries because of their inherent toxicities [91] (PARCOM 92/8, 2000; Directive 2000/60/EC,
2000; [92] Directive 2003/53/EC, 2003).
As was shown in planarians and numerous other non-vertebrates, organismal survival and ability
to respond to injury can be affected by NP exposure, similarly to what has been described for other
EDCs [93] (for examples, see [94,95]). In zebrafish, long-term exposure was shown to be a factor in
survival by reducing the reproduction rate [96]. Also, the survival and injury response may be reduced
because of the ability of NP to form adducts with DNA which leads to possible increases in mutation
rate [97].
(A) Cell death and organismal injury/survival: Exposure to NP has been reported to induce
apoptosis in various cell types, including sexually related cells, neurons, and neural stem cells [98].
As NP acts as a hormone mimic, the effect on sexual organs was expected; however, the apoptotic
induction in neurons and neuronal stem cells was more surprising. Nonetheless, the consequences of
such exposure during gestation and/or early brain development may be a very serious issue that has
not yet received full attention. These observed effects can be linked to hormone receptors mediated by
the signal transduction triggered by several types of surface receptors such as the FAS receptor (also
referred to as the “apoptosis antigen”) and the anion transporter SCL22A6 ([99] (see Figure 4B–D and
Supplementary Materials Tables S10–S12).
(B) Cancer: As an EDC, the health risk related to exposure to NP and/or NPE stems from their
ability to act as a hormone mimic [100]. Studies have linked NP with breast cancer, as it can mimic
17B-oestradiol and compete for the binding site of oestrogen receptors ESR1, ESR2, and the related
steroid receptor co-activator-1 (SRC-1/NCOA1) [101] (see Figure 4E and Supplementary Materials
Table S13). Also, a linkage with androgen receptors has also been reported. This suggests a potential
involvement of NP exposure with prostate cancer [102]. This mechanism may not involve a direct
interaction, but instead may be mediated by cross-talks with other hormone receptor(s). As there is
very little information connecting NP with other types of cancers, it is possible that its effect is exerted
in a compound manner with other EDCs or emerging water contaminants [90].
(C) Behavior: In addition to a propensity for promoting breast cancer, NP can also alter the
neuroendocrine system [90,103,104]. This interference may be associated, directly or indirectly, with
behavioral modifications, such as motility changes (swimming in fish), or social behaviors [103,105,106].
Interestingly, these modifications have been observed over two generations, suggesting a potentially
epigenetic mechanism of transmission [107]. As was the case for the cancer-associated effects, hormone
receptors (ESR1/2, NCOA1, see Figure 4F) may play a significant role in these behavioral changes.
Overall, as with most EDCs, NP can act on a plethora of genes, resulting in alterations of multiple
functions. The effects are most often mediated by changes in hormone receptor activity. Interestingly,
and similarly to endosulfan, NP exposure was shown, in human keratinocytes, to be linked with DNA
damage. This mechanism involved multiple factors, including ATM (ataxia-telangiectasia mutated),
the tumor suppressor p53, and the histone H2A.X (a marker of DNA double-strand breaks). The same
study linked NP to apoptosis, mediated by activation of poly(ADP-ribose) polymerase (PARP) and
caspase 3 [108]. Although not clearly outlined by our bioinformatics analysis, very recent literature has
connected NP with liver toxicity in mammals, including humans, as its pro-inflammatory properties
negatively affects liver cells [109].
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Figure 4. Nonyl phenol. Panel A: Structure of nonyl phenol and legend of symbols used for panels B to
F (as provided by IPA modeling “Bioprofiler” function). Cellular location and names of genes affected
by nonyl phenol exposure linked to, respectively, Panel B: Cellular response to organismal injury, Panel
C: Cell death, Panel D: Organismal survival, Panel E: Cancer, and Panel F: Behavior. Note that all
symbols and genes names and functions are described in Supplementary Materials Tables S10–S13.
The data were generated using human and animal model data. They include information from in vivo
and in vitro experiments.

3.5. Bisphenol A: Endocrine Disruptor
The rise of safety concerns related to chemicals released from consumer polycarbonate plastics has
led to a concomitant increase in the study of their potential toxic effects. Bisphenol A (BPA) is perhaps
the most widely recognized plastic-derived toxin (for structure, see Figure 5A). Although most of the
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major studies regarding the potential toxic effects of BPA used rats as an animal model, it has since been
found that primates metabolize BPA into an inactive form more efficiently than rodents, suggesting
that humans may be less susceptible to its toxic effects than initially believed [110]. Fortunately, despite
the uncertainty on the extent of BPA exposure to human toxicity, industries have ceased using BPA in
the manufacture of consumer plastics based on an amendment of FDA restrictions ([111] Fed. Reg.
41,899; 78 Fed. Reg. 41,840).
Although it appears that current and future plastics may be largely free of BPA, due to the
non-biodegradable nature of plastics, there is still concern regarding less direct routes of exposure.
In 2011, 19 landfills had their leachate tested for potential contaminants and 95% of these samples
tested positive for BPA [112]. It was also detected at levels known to negatively affect some invertebrate
species in untreated and treated wastewater, as well as in river water downstream from a paper
factory [113]. In a recent study to determine the possibility of food-borne exposure toxicity, researchers
grew vegetable plants using BPA-contaminated water and found that ingestion of contaminated
agriculture products would result in exposure to physiologically significant doses of BPA known to
cause observable developmental changes experimentally [114]. Thus, despite the absence of BPA in
modern plastics, former industrial practices may continue to have a negative impact on human health
through soil, water, and agriculture contamination.
The health risks associated with BPA exposure are primarily related to endocrine disruption,
as its main mechanism of action involves binding to estrogen receptors (ER), thus acting as a weak
estrogen [115,116]. A few of the major health research foci regarding the effect of BPA’s endocrine
disrupting activities are obesity, reproductive system dysfunction, immune dysfunction, and cancers
of the breast, prostate, and uterus [117]. The ability of BPA to disrupt the endocrine system may
also interfere with progesterone receptor expression in human endometrial tissue [116], leading to
an increased body mass and decreased glucose tolerance in males [118], negatively impacting male
fertility [119], and accelerated growth during childhood [120]. In addition to these effects, as an EDC,
BPA also targets genes involved in organismal injury, cell death, cancer, and behavior Figure 5B–F.
(A) Organismal injury: BPA can affect an organism’s ability to heal and respond to injury by the
disruption and alteration of the endocrine system (Figure 5B and Supplementary Materials Table S14).
Chronic BPA exposure has also been shown to reduce cardiac remodeling in mice [120], and is toxic to
bone mesenchymal stem cells [116]. In addition to affecting these systems, exposure to BPA also has an
impact on the Sertoli cells of the testes, [121] as well as on ovarian cells [81].
(B) Cell/organismal death: In addition to overt organismal injury, BPA exposure can lead to
apoptosis of spermatogenic cells [122]. In fact, many of the most toxic effects of BPA are observed in
cells of the reproductive system (Figure 5C,D and Supplementary Materials Tables S15 and S16). To
this end, BPA has been shown to negatively impact embryo and oocyte quality in mice by increasing
apoptosis [81,116]. Additionally, BPA exposure can result in the induction of apoptosis in mouse
pancreatic islet cells [116].
(C) Cancer: BPA exposure is specifically associated with breast cancers (Figure 5E and
Supplementary Materials Table S17), through the increased expression of HOXB9, a gene important in
mammary gland development known for its potential oncogenic properties [121]. This effect seems
to be related to its ability to mimic or activate similar pathways as those mediated by endogenous
estrogens. In addition, BPA exposure can also increase the expression of two matrix metalloproteinases,
MMP2 and MMP9 [111], the functions of which are linked with enhanced breast cancer migration
and invasion.
(D) Behavior: Sharing similar mechanisms with endogenous estrogens, it is not surprising that
BPA has behavioral effects (Figure 5F and Supplementary Materials Table S18). A systematic review
on BPA exposure in Canadian school-age children revealed that early-life and prenatal exposure was
associated with increased behavioral disorders, such as anxiety, depression, hyperactivity, inattention,
and conduct problems [115]. Additionally, children taking psychotropic medications were found to be
more likely to be susceptible to BPA exposure than those not taking such medications [120].
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Figure 5. Bisphenol A. Panel A: Structure of bisphenol A (BPA) and legend of symbols used for panels
B to F (as provided by IPA modeling “Bioprofiler” function). Cellular location and names of genes
affected by bisphenol A exposure linked to, respectively, Panel B: Cellular response to organismal
injury, Panel C: Cell death, Panel D: Organismal death, Panel E: Cancer, and Panel F: Behavior. Note
that all symbols and genes names and functions are described in Supplementary Materials Tables
S14–S18. The data were generated using human and animal model data. They include information
from in vivo and in vitro experiments.

BPA is probably the most notorious EDC and has been known for several years to be a cause of
cellular toxicity. As mentioned earlier, the recent banning of its use will hopefully lead to a decrease in
its abundance in major river basins, as well as in tap/drinking water. Studies involving BPA degradation
during chemical remediation using Persulfate have indicated that, despite the efficient degradation
of BPA itself, its degradation products have genotoxic effects of their own [123,124]. This highlights
the fact that the risks associated with prior BPA use are still a serious concern for human health.
Appearing to be a common theme for EDC exposure, BPA’s mode of action is also likely correlated
with increased oxidative stress, which would contribute to a BPA-associated increase in DNA damage
in mammals [125].
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3.6. Buprenorphine: Opioid
Buprenorphine is now considered to be a substance of interest as a potential emerging water
contaminant (for structure, see Figure 6A), based on its increased usage and prevalence as a treatment
option for opioid addiction. Pregnant women abusing opioids present an additional problem compared
to other drug abusers, as supporting these women in overcoming their addiction must be balanced with
the serious concerns in protecting the fetus from the dangers of withdrawal. To palliate the negative
effects of opioid abuse, one of the preferred agents of maintenance therapy in these pregnant patients
is the opioid derivative buprenorphine, as it has a higher potential to reduce neonate abstinence
syndrome (NAS, [126]) compared to methadone. Buprenorphine is a mixed agonist-antagonist of
opioid receptors—a partial agonist of µ opioid receptors (MOR), and an antagonist of κ opioid receptors
(KOR) and δ opioid receptors (DOR). In addition to its primary effects, the metabolic products of
buprenorphine degradation, though differing in opioid receptor selectivity, half-life, and potency,
may also be considered of concern for water quality.
Despite its status as a controlled substance, there is potential that physiologically relevant amounts
of buprenorphine may be contaminating drinking water. In France, for example, buprenorphine was
initially detected at levels of 40 ng/L in sewage water effluent at one study site, and at levels varying
from 42 ng/L to 195 ng/L in sewage water influent samples at three additional study sites [26]. An earlier
study, focusing on the Paris area, also detected low levels of buprenorphine from samples of wastewater
entering four treatment plants [85]. While these levels correspond to small therapeutic doses compared
to those prescribed to human patients, there is the possibility of a cumulative long-term effect through
chronic exposure to the contaminated drinking water. The recent increase in buprenorphine use may
eventually enhance its presence in water supplies. Therefore, it is important to identify the genes which
may mediate any chronic effects of low-dose and long-term buprenorphine exposure. Consequently,
as with our selected EDCs, we used our IPA® analysis to identify the buprenorphine-targeted genes
involved in organismal injury, cell death, cancer, and behavior (Figure 6).
(A) Organismal injury/survival and cell death: Aside from the analgesic properties of opioids, an
important secondary effect is increasing cell death, particularly of cells in the nervous and immune
systems (Figure 6B,C and Supplementary Materials Tables S19–S21). Consequently, opioid addicts
have been found to have decreased number of circulating progenitor stem cells [116]. Intriguingly,
buprenorphine seems to exert a dose-dependent effect, either promoting cell survival and differentiation
or increasing cell death and apoptosis [6,119,127]. Buprenorphine exposure in neuronal cells has
also been shown to lead to caspase-3 activation and efflux of cytochrome c from the mitochondria,
indicative of activation of the mitochondrial pathway of apoptosis [118].
(B) Cancer: Because of the associated addiction risks, medical practice for chronic pain in the United
States is moving away from the use of opioids as treatment, except in cases where the benefits outweigh
the risk [128] (Figure 6D and Supplementary Materials Table S22). However, due to the decreased
abuse and addiction potential associated with buprenorphine compared to other pain management
drugs, it is being investigated as an attractive substitute for managing chronic pain associated with
cancer. However, given the previously discussed effects of opioids on cell populations, it is important
to consider all the potential effects that buprenorphine might have on cancer cell populations.
For some time, it has been known that buprenorphine has a dose-dependent effect on serum
prolactin levels in human, as low doses increase serum prolactin production levels while high doses of
buprenorphine decrease them. Importantly, both the positive and negative effects on serum prolactin
production are blocked by the opioid receptor antagonist naloxone [111]. Aside from the behavioral
implications associated with this effect, prolactin has also been implicated in breast cancer [98] as high
levels of prolactin receptor (PRLR) are expressed in some breast cancers, leading to increased cancer
cell invasiveness [129].
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Figure 6. Buprenorphine. Panel A: Structure of buprenorphine and legend of symbols used for panels
B to E (as provided by IPA modeling “Bioprofiler” function). Cellular location and names of genes
affected by buprenorphine exposure linked to, respectively, Panel B: Cellular response to organismal
injury and survival, Panel C: Cell death, Panel D: Cancer, and Panel E: Behavior. Note that all symbols
and genes names and functions are described in Supplementary Materials Tables S19–S23. The data
were generated using human and animal model data. They include information from in vivo and
in vitro experiments.

(C) Behavior: Although prolactin is most directly associated with lactation and some aspects of
maternal behavior [128], the other pathways involved in prolactin release should also be considered
when analyzing the effects of buprenorphine (Figure 6E and Supplementary Materials Table S23).
One of the key feedback pathways involved in prolactin release is dopamine release from the
hypothalamus [130], as high dopamine levels exert an inhibitory effect on the release of prolactin [131].
The fact that buprenorphine can both increase or decrease prolactin levels supports the hypothesis
that it interacts with the dopaminergic systems of the brain, and, also supporting this conclusion,
it has been demonstrated that buprenorphine exposure affects the dopamine receptor density in the
striatum [123]. In turn, dopamine is widely implicated in the pathology of psychiatric disorders.
Though buprenorphine is not a bona fide EDC, its potential to become a major water contaminant
justifies its inclusion in our study. Its presence in the tap/drinking water in large urban areas (see
Table 1) suggests that buprenorphine contamination is becoming a serious issue in regions currently
dealing with any type of “opioid crisis”. As opposed to the EDCs that we investigated, which seem to
share a mode of action strongly involving oxidative stress and DNA damage, buprenorphine does
not appear to work in a similar manner, despite a few reports which link its toxicity with increased
apoptosis [132].
4. Conclusions
As has become obvious over the last few years, water quality and emerging contaminants have
become a serious concern for public health. Our ontology analysis clearly demonstrates that our selected
examples have a plethora of negative effects on cellular systems, spanning from micro-organisms
to human. The IPA® analytical settings used for our study outlined the most commonly observed
effects, based on the current available literature, and we decided to focus on the to five “families” of
function most often outlined by our search. The deleterious effects related to endocrine mimicking
properties are a major concern directly related to exposure to these emerging contaminants. Even
very low concentrations, such as those detected in the Ohio River (see Table 1), can lead to serious
behavioral changes, as exemplified by the effects of buprenorphine anxiety, depression, hyperactivity,
inattention, and conduct problems, as shown by Ejaredar et al. [133]. As expected, exposure to EDCs
affects endocrine functions, mostly through standard interactions with hormone receptors, acting either
as activators or inhibitors. These hormonal disruptions cause increased risks of developing various
types of cancer (for example, but not limited to: prostate, breast, and ovarian cancers). In addition
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to these oncogenic properties, exposure to EDCs in our water supply clearly affects basic cellular
functions as well, such as the ability to control cell death and survival (commonly mediated through
modifications of genes involved in the apoptotic pathway).
From our analysis and based on recent reports, a common theme emerges connecting EDC
exposure and increased oxidative stress which eventually leads to DNA damage. All the investigated
EDCs in this study share a common link with this mode of action, as evidenced by studies on various
organisms, from invertebrates to humans. This increased inability to compensate for EDC-induced
DNA damage may play an important role in the toxicity of these products. Therefore, the cytotoxicity
of these emerging contaminants might be provoked by, or be the consequence of, an underlying
genotoxicity manifesting itself in a variety of ways, affecting a litany of genes involved in nearly all
aspects of cell development and viability.
A potential explanation for why so many different genes can be affected by EDC or opioid
exposure is that their mode of action could possibly be associated with epigenetic changes, although
this possibility currently remains understudied. DNA methylation, as well as histone post-translational
modifications (PTM), are critical epigenetic elements involved in regulating gene expression (for recent
review, see Corella and Ordova, 2017 [134]). and an increasing number of publications have now
demonstrated a connection between EDC exposure and the deregulation of DNA methylation at
specific chromosomal locations.
Such connections between epigenetic regulations and EDC exposure have been reported for
atrazine, the mode of action of which appears to affect the global levels of DNA methylation [135,136]
as well as that of specific histone PTMs [137]. Highlighting the negative impact of EDC exposure,
these epigenetic events have even been shown to affect rat sperm cells in a transgenerational manner,
changing the DNA methylation pattern for up to three generations [138].
Endosulfan has also been shown to affect the expression of specific genes in an epigenetic
manner [139,140], potentially modulating the expression profile of the histone modifiers histone
deacetylase (HDAC) HDAC1 and 3, as well as histone methyltransferase PRMT5 and EZH2, in breast
cancer cells [140]. This results in an increase in the histone PTMs tri-methylated histone H3 Lysine 27
(H3K27me3) and di-methylation of histone H4 arginine 3 (H4R3me2), two epigenetic modifications that
are known to be involved in the regulation of gene expression by promoting the recruitment of activator
or repressor proteins. EDC-mediated epigenetic changes in levels of DNA methylation targeting ERα
have also been linked to impaired fertility in female rats mediated by endosulfan activity [139].
Nonyl phenol exposure can have an effect both on DNA methylation and on histone PTM patterns.
The changes in DNA methylation were the first reported by [107], but NP exposure was more recently
found to result in the deregulation of histone PTMs such as H3 and H4 acetylation, as well as the
trimethylation of histone H3 Lysine 4 (H3K4me3) [141] in dendritic [141,142] and testicular cells [143].
BPA exposure can also lead to disruptions in DNA methylation and histone acetylation
patterns [144]. Also, as was shown with atrazine exposure, a potential epigenetic transgenerational
effect (on insulin production in this case) has been reported in F1 and F2 mouse offspring after maternal
BPA exposure [145]. Additionally, this effect may be linked with changes in germ line cells affecting
the animal’s fertility (see Chianese et al., 2017 for review [146]).
Buprenorphine has also been suspected to act at an epigenetic level [147,148], as it has been linked
with changes in gene expression of the methyl-DNA binding protein MeCP2, an important regulator of
brain development, as well as several histone PTMs ([131,149], Georgel’s laboratory, unpublished data).
Although these changes have not been fully characterized, a growing number of studies point
towards complex regulatory mechanisms on an epigenetic level being strongly affected by novel
emerging water contaminants. A systematic approach will be required to better understand all the
implications which have been revealed to link EDCs and opioid water contamination with epigenetic
events. Such an approach would potentially lead to a better understanding of the various, and often
unrelated, cytotoxic and genotoxic effects mediated by emerging contaminants in our water supply.
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The evidence collected through multiple studies, using a variety of model systems, including
human cell lines, indicate that exposure to EDCs and buprenorphine, as expected, influences the
expression of many genes involved in a variety of cellular steroid response events. The effects of EDCs
have also been commonly linked with inflammation response, as well as changes in the expression of
genes involved in the regulation of the cellular Red-ox potential (possibly linked to an increase in the
generation of DNA-damaging radicals). The apparent link between EDC exposure and DNA damage
was not as easily predictable when considering the chemical nature and makeup of EDCs. Such an
increase in cellular DNA damage, which is non-sequence-specific in nature, may partially explain
why such a variety of genes in various and seemingly unrelated cellular functions can be affected.
The implied correlations from evidence which suggests the involvement of epigenetic re-mapping may
also contribute to explaining the mechanisms of action for EDCs and opioids. The epigenetic changes
over potentially large sections of the genome would also contribute to explaining the pleiotropic nature
of the cells’ and organisms’ responses to EDC exposure.
If each emerging contaminant included in our analysis can individually affect at the level of gene
expression of specific genes and contributes to DNA damage and epigenomic changes, the combinatorial
effect of EDCs might prove to be additive or even synergistic in nature. This consideration would
require a new and more global research strategy to be developed to investigate the holistic effects
of exposure to multiple EDCs, as the combined effects of exposure to these chemicals may be more
detrimental and widespread than initially anticipated. Long-term exposure studies involving the
monitoring of genome stability and global epigenetic events would likely provide us with an improved
view of the global scale of the cellular and organismal responses to these emerging contaminants.
Supplementary Materials: The following are available online at http://www.mdpi.com/2073-4441/11/12/2615/s1,
List of tables (results from ontologic/metabolomic analysis using Ingenuity Pathways Analysis): Table S1: Atrazine
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